Table 2.

PBPC Yield and Transfusion Requirements

Variable Prior RadiationrhTPO Group Control GroupP Value*
Median Range N MedianRange N
No. of aphereses to procure  No  1  1-3 22  2  1-5+  14  .0005  
>3 × 106CD34+ cells/kg  Yes  1  1-2  4  3  3-4+ 6  .001  
 All patients  1  1-3  26  3  1-5+ 20  <.0001 
CD34+ × 106/kg/first apheresis  No 3.6  1.3-18  22  1.3  0.3-4.2  14  .0005 
 Yes  5.1  2.4-15  4  0.7  0.6-0.9  4  .014 
 All patients  4.1  1.3-17.6  26  0.8  0.3-4.2 20  .0003  
No. of RBC transfusions No  3  2-7 21  4.5  2-10  14  .07  
 Yes  3.5  3-4 2  4  3-8  6  .37  
 All patients  3  2-7 23  4  2-10  20  .02  
No. of platelet transfusions No  4  0-10  21  5  2-19  14  .09  
 Yes 3  2-4  2  6.5  3-11  6  .2  
 All patients 4  0-10  23  5  2-19  20  .02 
Variable Prior RadiationrhTPO Group Control GroupP Value*
Median Range N MedianRange N
No. of aphereses to procure  No  1  1-3 22  2  1-5+  14  .0005  
>3 × 106CD34+ cells/kg  Yes  1  1-2  4  3  3-4+ 6  .001  
 All patients  1  1-3  26  3  1-5+ 20  <.0001 
CD34+ × 106/kg/first apheresis  No 3.6  1.3-18  22  1.3  0.3-4.2  14  .0005 
 Yes  5.1  2.4-15  4  0.7  0.6-0.9  4  .014 
 All patients  4.1  1.3-17.6  26  0.8  0.3-4.2 20  .0003  
No. of RBC transfusions No  3  2-7 21  4.5  2-10  14  .07  
 Yes  3.5  3-4 2  4  3-8  6  .37  
 All patients  3  2-7 23  4  2-10  20  .02  
No. of platelet transfusions No  4  0-10  21  5  2-19  14  .09  
 Yes 3  2-4  2  6.5  3-11  6  .2  
 All patients 4  0-10  23  5  2-19  20  .02 
*

Comparisons between the rhTPO v control groups were performed using the Wilcoxon rank-sum test. F test, adjusting for prior radiation, was used to combine strata in the overall analysis.

Transfusion requirements were evaluated in 23 assessable patients.

or Create an Account

Close Modal
Close Modal